retatrutide ly3437943 triple agonist glp-1 gip glucagon (LY3437943): Mechanism of Action and Research Overview Tirzepatide vs Retatrutide: Dual vs

All content on our website is provided for educational use exclusively

Understanding the Risks and Making Informed Choices What We Know for Sure Research clearly shows: GLP-1 medications should not be used during pregnancy A 2-month washout period is necessary before conceiving Accidental early exposure doesnt automatically mean harm Animal studies show potential risks to developing babies Human data is limited but somewhat reassuring What We Dont Know Yet We still need more research on: Long-term effects on babies exposed during pregnancy Whether different GLP-1 drugs have different risk levels Impact on babies when used in the second and third trimesters Effects on breastfeeding and breast milk Making Your Decision Talk openly with your healthcare team about: Your weight loss goals Your pregnancy timeline Your overall health needs Your risk factors Your emotional readiness Together, you can create a plan that protects your health and your future baby

Therapeutic Applications and Considerations BPC 157 is explored for several recovery-related use cases, including joint support, soft-tissue healing, gastrointestinal irritation, and mucosal repair

doi: 10.1038/ejcn.2013.90

GLP-1 and Hair Loss:What's the Connection?A clinical guide to why GLP-1s like Ozempic and Mounjaro are linked to hair shedding, and what to ask a clinician about it

If your health insurance plan does not cover GLP-1s for your condition, or they do not cover your medication of choice, its always an option to pursue coverage by exception or to submit an appeal